Practice question

Answer the question and get instant feedback.

MediumEndocrinologyType 2 Diabetes Mellitusukmlamrcgp aktpanemrcem sbamrcp part 1prescribing safety assessment

A 62-year-old woman with type 2 diabetes, managed with metformin 1g BD, presents for her annual review. Her HbA1c is 62 mmol/mol (Target <53 mmol/mol). She has established cardiovascular disease (previous myocardial infarction). Her eGFR is >60 mL/min/1.73m$^2$. According to NICE NG28, what is the most appropriate second-line agent to add?

Practice more on iatroX

Educational content. Not a substitute for clinical judgement or local policy.